BLI Technology for Antibody Detection Service
Biofilm layer interferometry is a non-labeled analytical detection technique based on optical interference signals for kinetic analysis or rapid detection of biomolecules. It has been applied to the analysis of interactions between proteins, nucleic acids, lipids, sugars and other biomolecules because of its advantages of real-time analyte information, fast analysis speed and low sample consumption; the advantages of low sample size and high specificity also provide a basis for the application of this technique in rapid detection. This technique has been applied to the analysis of protein, nucleic acid, lipid, sugar and other biomolecule interactions. CD BioSciences provides professional BLI technology for antibody detection service to help customers complete biofilm related research.
Specific Antibody Detection Approaches We Offer
- Detection of antibody and antigen affinity
- High-throughput quantitative detection of monoclonal antibodies
- Antibody content detection
- Antibody and complement affinity detection
- Antibody and fc receptor protein affinity detection
In addition to the above services, we offer the following services for your research options:
- Detection of Ka, Kd and KD of antigen-antibody binding
- Affinity ranking and dissociation rate ranking of crude supernatant samples
- Antibody engineering and affinity maturation
Advantages
- Ability to provide a unique high-throughput platform: 8 to 16 samples can be detected simultaneously, the highest throughput of any non-labeling technology.
- Real-time determination of kinetic data: enables the detection of molecular interaction kinetic data, enabling the detection of transient molecular interactions.
- low detection volume: only a small nanomolar amount of sample is required, which can be used to analyze molecular samples that are difficult to separate.
- Wide range of applications: direct detection of crude samples, tolerance to various solution environments, and only molecules bound to the sensor surface are detected.
Sample Requirements
- Buffer: PBS, HEPPS, etc. without organic reagents, without Tris
- Protein sample (with antibody): 200 ug, concentration >0.5 mg/ml
- Peptide sample: 200 ug, concentration>1mg/ml
- Compound small molecule: 200 ug, concentration>1 mg/ml
Provided by Clients
Please inform us of your specific BLI technology for antibody detection service details, and we can provide customized solutions for different projects.
Service Process
Our Features
- CD BioSciences has established a proven biofilm technology platform for a variety of applications. We'll help you design the right biofilm technology service to aid your scientific research.
- CD BioSciences is a leading biofilm technology company offering a trusted suite of services and solutions, especially with our extensive experience in biofilm testing.
- With our talented people and years of experience, we can fully meet your project requirements and budget in exploring fluorescent markers of biofilms.
Deliverables
- Related experimental results raw data
- Antibody detection results
- Remaining samples
- Experimental report
- Data analysis
- Image and result analysis
- Summary of relevant calculation parameters
Why Choose Us?
CD BioSciences is committed to providing customers with comprehensive BLI technology for antibody detection service to help customers study biofilms more efficiently. Our excellent technology platform can realize a variety of biofilm technology services, and the praise from customers all over the world is the proof of our high-quality services. Please feel free to contact us for more detailed information, our scientists will tailor the most reasonable plan for your project.
For research use only, not intended for any clinical use.
Related Services:
